Impact of Paclitaxel Dose on Tissue Pharmacokinetics and Vascular Healing
- 1 July 2015
- journal article
- research article
- Published by Elsevier BV in JACC: Cardiovascular Interventions
- Vol. 8 (8), 1115-1123
- https://doi.org/10.1016/j.jcin.2015.03.020
Abstract
No abstract availableKeywords
Funding Information
- Boston Scientific Corporation
This publication has 16 references indexed in Scilit:
- Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healingOpen Heart, 2014
- Drug-Eluting Balloon in Peripheral Intervention for the Superficial Femoral ArteryJACC: Cardiovascular Interventions, 2013
- Tissue Uptake, Distribution, and Healing Response After Delivery of Paclitaxel via Second-Generation Iopromide-Based Balloon Coating: A Comparison With the First-Generation Technology in the Iliofemoral Porcine ModelJACC: Cardiovascular Interventions, 2013
- Evaluation of Efficacy and Dose Response of Different Paclitaxel-Coated Balloon Formulations in a Novel Swine Model of Iliofemoral In-Stent RestenosisJACC: Cardiovascular Interventions, 2012
- Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipientsEuroIntervention, 2011
- Drug-eluting balloon: Very short-term exposure and overlappingThrombosis and Haemostasis, 2009
- Inhibition of Restenosis in Femoropopliteal ArteriesCirculation, 2008
- Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheterClinical Research in Cardiology, 2008
- Local Delivery of Paclitaxel to Inhibit Restenosis during Angioplasty of the LegThe New England Journal of Medicine, 2008
- Treatment of Coronary In-Stent Restenosis with a Paclitaxel-Coated Balloon CatheterThe New England Journal of Medicine, 2006